{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:48:32Z","timestamp":1794001712855,"version":"4.8.0"},"reference-count":172,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Diabetic kidney disease (DKD) is one of the major complications of diabetes, and its pathological progression is closely associated with lipid metabolic reprogramming. Under diabetic conditions, renal cells undergo significant lipid metabolic abnormalities, including increased lipid uptake, impaired fatty acid oxidation, disrupted cholesterol efflux, and enhanced lipid catabolism, as adaptive responses to metabolic stress. These changes result in the accumulation of lipids such as free fatty acids, diacylglycerol, and ceramides, leading to lipotoxicity that triggers inflammation and fibrosis. Hypoxia in the DKD microenvironment suppresses fatty acid oxidation and promotes lipid synthesis through the HIF-1\u03b1 pathway, while chronic inflammation exacerbates lipid metabolic disturbances via inflammatory cytokines, inflammasomes, and macrophage polarization. Targeting lipid metabolism represents a promising therapeutic strategy for alleviating DKD; however, further clinical translational studies are warranted to validate the efficacy and safety of these approaches.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1549484","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:27:00Z","timestamp":1745544420000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies"],"prefix":"10.3389","volume":"16","author":[{"given":"Wei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Haoyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Pengfei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Anzhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Lili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Linhua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"B1","unstructured":"Meda\n              E\n            \n            \n              Pavkov\n              YM\n            \n          \n          IDF diabetes atlas\u2013\u2014Diabetes and kidney disease"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.dld.2024.01.021","article-title":"El insights into the effect of SGLT-2 inhibitor empagliflozin on hepatic damage in diabetic obese zucker rats","volume":"56","author":"Pirozzi","year":"2024","journal-title":"Digestive Liver Disease"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115688","article-title":"Protective effect of soy isolate protein against streptozotocin induced gestational diabetes mellitus via TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"168","author":"Wang","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072632","article-title":"Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities","volume":"21","author":"Opazo-R\u00edos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-023-05947-1","article-title":"Single-cell transcriptomic profiles in the pathophysiology within the microenvironment of early diabetic kidney disease","volume":"14","author":"Tsai","year":"2023","journal-title":"Cell Death Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01802-x","article-title":"Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression","volume":"56","author":"Abedini","year":"2024","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41581-022-00592-x","article-title":"Immunometabolic rewiring of tubular epithelial cells in kidney disease","volume":"18","author":"van der Rijt","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.95216","article-title":"Lipid homeostasis in diabetic kidney disease","volume":"20","author":"Wang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2023.2292753","article-title":"CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function","volume":"45","author":"Niu","year":"2023","journal-title":"Ren Fail"},{"key":"B13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12944-024-02041-z","article-title":"Topical rhubarb charcoal-crosslinked chitosan\/silk fibroin sponge scaffold for the repair of diabetic ulcers improves hepatic lipid deposition in db\/db mice via the AMPK signalling pathway","volume":"23","author":"Tan","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.156748","article-title":"Deficiency of CFB attenuates renal tubulointerstitial damage by inhibiting ceramide synthesis in diabetic kidney disease","volume":"7","author":"Sun","year":"2022","journal-title":"JCI Insight 22"},{"key":"B15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","article-title":"The key role of altered tubule cell lipid metabolism in kidney disease development","volume":"106","author":"Lee","year":"2024","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/jci165654","article-title":"Molecular pathways that drive diabetic kidney disease","volume":"133","author":"Mohandes","year":"2023","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i5.524","article-title":"New insights into renal lipid dysmetabolism in diabetic kidney disease","volume":"12","author":"Mitrofanova","year":"2021","journal-title":"World J Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2018.12.008","article-title":"Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression","volume":"71","author":"Su","year":"2019","journal-title":"Pharmacol Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41419-020-03199-x","article-title":"Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.2337\/db05-0603","article-title":"Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in akita and OVE26 mice with type 1 diabetes","volume":"55","author":"Proctor","year":"2006","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1681\/ASN.2017030314","article-title":"Kidney proximal tubule lipoapoptosis is regulated by fatty acid transporter-2 (FATP2)","volume":"29","author":"Khan","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136845","article-title":"Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression","volume":"5","author":"Khan","year":"2020","journal-title":"JCI Insight"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","article-title":"KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease","volume":"33","author":"Mori","year":"2021","journal-title":"Cell Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e136845","DOI":"10.1172\/jci172963","article-title":"ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules","volume":"134","author":"Mukhi","year":"2023","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.nutr.27.061406.093618","article-title":"ChREBP, a transcriptional regulator of glucose and lipid metabolism","volume":"27","author":"Postic","year":"2007","journal-title":"Annu Rev Nutr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109452","article-title":"F6P\/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish","volume":"122","author":"Gong","year":"2023","journal-title":"J Nutr Biochem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01160-0","article-title":"Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1\/ChREBP pathway","volume":"45","author":"Lu","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.165817","article-title":"Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy","volume":"8","author":"Lu","year":"2023","journal-title":"JCI Insight."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00568-y","article-title":"Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth","volume":"4","author":"Cheng","year":"2022","journal-title":"Nat Metab"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.2337\/diabetes.54.8.2328","article-title":"Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes","volume":"54","author":"Wang","year":"2005","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mju041","article-title":"SREBP-1 is a novel mediator of TGF\u03b21 signaling in mesangial cells","volume":"6","author":"Chen","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10020-022-00545-x","article-title":"PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease","volume":"28","author":"Zhao","year":"2022","journal-title":"Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.10.039","article-title":"Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease","volume":"101","author":"Yoshioka","year":"2022","journal-title":"Kidney Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203236","article-title":"The contribution of lipotoxicity to diabetic kidney disease","volume":"11","author":"Schelling","year":"2022","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14502","article-title":"High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in china: Findings from the china cardiometabolic disease and cancer cohort (4C) study","volume":"23","author":"Gong","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1040319","article-title":"The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.040","article-title":"Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and alport syndrome","volume":"98","author":"Liu","year":"2020","journal-title":"Kidney Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155377","article-title":"ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease","volume":"139","author":"Zhang","year":"2023","journal-title":"Metabolism"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/jci125316","article-title":"ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes","volume":"129","author":"Ducasa","year":"2019","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0399","article-title":"Cyclodextrin protects podocytes in diabetic kidney disease","volume":"62","author":"Merscher-Gomez","year":"2013","journal-title":"Diabetes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1038\/s41467-021-24890-3","article-title":"Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease","volume":"12","author":"Wright","year":"2021","journal-title":"Nat Commun"},{"key":"B43","article-title":"Liver X receptors alpha and beta regulate renin expression","volume":"115","author":"Morello","year":"2005","journal-title":"vivo. J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.159","article-title":"Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters","volume":"80","author":"Caldas","year":"2011","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130317","article-title":"Increased lipogenesis and impaired \u03b2-oxidation predict type 2 diabetic kidney disease progression in american indians","volume":"4","author":"Afshinnia","year":"2019","journal-title":"JCI Insight"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171961","article-title":"Tubular CPT1A deletion minimally affects aging and chronic kidney injury","volume":"9","author":"Hammoud","year":"2024","journal-title":"JCI Insight"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.03.170","article-title":"Atgl gene deletion predisposes to proximal tubule damage by impairing the fatty acid metabolism","volume":"487","author":"Chen","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2023.07.004","article-title":"Lipin-1 deficiency deteriorates defect of fatty acid \u03b2-oxidation and lipid-related kidney damage in diabetic kidney disease","volume":"266","author":"Lin","year":"2024","journal-title":"Transl Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41419-021-03452-x","article-title":"Characterization of ferroptosis in kidney tubular cell death under diabetic conditions","volume":"12","author":"Kim","year":"2021","journal-title":"Cell Death Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.05.024","article-title":"NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2\/Gpx4 pathway","volume":"187","author":"Li","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0063","article-title":"Novel identified circular RNA, mmu_mmu_circRNA_0000309, involves in germacrone-mediated improvement of diabetic nephropathy through regulating ferroptosis by targeting miR-188-3p\/GPX4 signaling axis","volume":"36","author":"Jin","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"B54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","article-title":"PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis","volume":"24","author":"Zhang","year":"2022","journal-title":"Nat Cell Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173574","article-title":"Ferroptosis involves in renal tubular cell death in diabetic nephropathy","volume":"888","author":"Wang","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-051022-014433","article-title":"Control of cell death in health and disease","volume":"19","author":"Kayagaki","year":"2024","journal-title":"Annu Rev Pathol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.05.130","article-title":"Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes","volume":"105","author":"Al-Rasheed","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-016-0771-3","article-title":"The attenuation of chlorogenic acid on oxidative stress for renal injury in streptozotocin-induced diabetic nephropathy rats","volume":"39","author":"Ye","year":"2016","journal-title":"Arch Pharm Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-023-04501-1","article-title":"Circular RNA COL1A2 mediates high glucose-induced oxidative stress and pyroptosis by regulating MiR-424-5p\/SGK1 in diabetic nephropathy","volume":"195","author":"Zhuang","year":"2023","journal-title":"Appl Biochem Biotechnol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"8056","DOI":"10.1038\/s41467-023-43775-1","article-title":"The AMPK-sirtuin 1-YAP axis is regulated by fluid flow intensity and c ontrols autophagy flux in kidney epithelial cells","volume":"14","author":"Claude-Taupin","year":"","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2016.08.006","article-title":"Thioredoxin-interacting protein regulates lipid metabolism via Akt\/mTOR pathway in diabetic kidney disease","volume":"79","author":"Du","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99271","article-title":"mTOR-mediated podocyte hypertrophy regulates glomerular integrity in m ice and humans","volume":"4","author":"Puelles","year":"","journal-title":"JCI Insight"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.6.14930","article-title":"The integral role of mTOR in lipid metabolism","volume":"10","author":"Soliman","year":"2011","journal-title":"Cell Cycle"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217994","article-title":"Critical role for AMPK in metabolic disease-induced chronic kidney disease","volume":"21","author":"Juszczak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.462","article-title":"Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury","volume":"85","author":"Decl\u00e8ves","year":"2014","journal-title":"Kidney Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00648-y","article-title":"Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases","volume":"19","author":"Huynh","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111454","article-title":"Mechanism and application of metformin in kidney diseases: An update","volume":"138","author":"Song","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.89","article-title":"PPARalpha: an emerging therapeutic target in diabetic microvascular damage","volume":"6","author":"Hiukka","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2023.09.039","article-title":"The E3 ligase Trim63 promotes podocyte injury and proteinuria by targeting PPAR\u03b1 to inhibit fatty acid oxidation","volume":"209","author":"Chen","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02993","article-title":"New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages","volume":"10","author":"Batista-Gonzalez","year":"2019","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11033-023-09198-3","article-title":"Desmosterol-driven atypical macrophage polarization regulates podocyte dynamics in diabetic nephropathy","volume":"51","author":"Qi","year":"2024","journal-title":"Mol Biol Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.09.017","article-title":"Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome","volume":"1801","author":"Prieur","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.05.019","article-title":"Improvement of LXR-mediated lipid metabolism in nephrotic model kidney accompanied by suppression of inflammation and fibrosis","volume":"666","author":"Yonezawa","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.11.033","article-title":"Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors","volume":"182","author":"Kiss","year":"2013","journal-title":"Am J Pathol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e18364","DOI":"10.1111\/jcmm.18364","article-title":"Molecular mechanism of renal lipid accumulation in diabetic kidney disease","volume":"28","author":"Fang","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16417","article-title":"Effect of triggering receptor expressed on myeloid cells 2-associated alterations on lipid metabolism in macrophages in the development of non-alcoholic fatty liver disease","volume":"39","author":"Ji","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy","volume":"50","author":"McLaren","year":"2011","journal-title":"Prog Lipid Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0922-5","article-title":"Macrophage-mediated glucolipotoxicity via myeloid-related protein 8\/toll-like receptor 4 signaling in diabetic nephropathy","volume":"18","author":"Kuwabara","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2578-1","article-title":"Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by toll-like receptor 4 in mice","volume":"55","author":"Kuwabara","year":"2012","journal-title":"Diabetologia"},{"key":"B85","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00011-008-7171-1","article-title":"Tubular epithelial cells have the capacity to transdifferentiate into CD68-positive macrophage-like cells by oxidative stress","volume":"57","author":"Tanaka","year":"2008","journal-title":"Inflammation Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","article-title":"Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism","volume":"32","author":"Fu","year":"2020","journal-title":"Cell Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155724","article-title":"CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease","volume":"150","author":"Zuo","year":"2024","journal-title":"Metabolism"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306365","article-title":"Dock5 deficiency promotes proteinuric kidney diseases via modulating podocyte lipid metabolism","volume":"11","author":"Qu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.04.021","article-title":"Rho-associated, coiled-coil-containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism","volume":"102","author":"Nagai","year":"2022","journal-title":"Kidney Int"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.11.010","article-title":"Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db\/db mice","volume":"91","author":"Li","year":"2017","journal-title":"Kidney Int"},{"key":"B91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12929-022-00814-1","article-title":"Inhibition of ChREBP ubiquitination via the ROS\/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells","volume":"29","author":"Kim","year":"2022","journal-title":"J BioMed Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.01.004","article-title":"Reducing VEGF-b signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease","volume":"25","author":"Falkevall","year":"2017","journal-title":"Cell Metab"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00007","article-title":"Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis","volume":"4","author":"Kanasaki","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1681\/asn.0000000000000328","article-title":"WWP2 regulates renal fibrosis and the metabolic reprogramming of profibrotic myofibroblasts","volume":"35","author":"Chen","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0757","article-title":"Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy","volume":"4","author":"Singh","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05380-z","article-title":"Hypoxia and hypoxia-inducible factors in diabetes and its complications","volume":"64","author":"Catrina","year":"2021","journal-title":"Diabetologia"},{"key":"B98","article-title":"Progressive renal disease: the chronic hypoxia hypothesis","volume":"65","author":"Fine","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1038\/s41598-021-84590-2","article-title":"Comprehensive metabolomic study of the response of HK-2 cells to hyperglycemic hypoxic diabetic-like milieu","volume":"11","author":"Vald\u00e9s","year":"2021","journal-title":"Sci Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122860","article-title":"Renal lipids and oxygenation in diabetic mice: noninvasive quantificat ion with MR imaging","volume":"269","author":"Peng","year":"","journal-title":"Radiology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.cmet.2024.05.014","article-title":"Electron transport chain inhibition increases cellular dependence on purine transport and salvage","volume":"36","author":"Wu","year":"2024","journal-title":"Cell Metab"},{"key":"B102","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s42255-020-0211-z","article-title":"Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism","volume":"2","author":"Aregger","year":"2020","journal-title":"Nat Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2551-y","article-title":"Na(+) controls hypoxic signalling by the mitochondrial respiratory chain","volume":"586","author":"Hernansanz-Agust\u00edn","year":"2020","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41419-020-2544-7","article-title":"Sodium-glucose cotransporter 2 inhibition suppresses HIF-1\u03b1-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice","volume":"11","author":"Cai","year":"2020","journal-title":"Cell Death Dis 22"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2014050457","article-title":"Disruption of renal tubular mitochondrial quality control by myo-inositol oxygenase in diabetic kidney disease","volume":"26","author":"Zhan","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz2597","article-title":"Endothelial-to-mesenchymal transition compromises vascular integrity to induce myc-mediated metabolic reprogramming in kidney fibrosis","volume":"13","author":"Lovisa","year":"2020","journal-title":"Sci Signal"},{"key":"B107","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.krcp.2015.05.003","article-title":"Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold","volume":"34","author":"Goligorsky","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00411-9","article-title":"Phenotypic diversity and metabolic specialization of renal endothelial cells","volume":"17","author":"Dumas","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00463.2014","article-title":"Interactions between HIF-1\u03b1 and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease","volume":"309","author":"Li","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/srep03793","article-title":"HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs","volume":"4","author":"Zhao","year":"2014","journal-title":"Sci Rep"},{"key":"B112","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-017-01965-8","article-title":"HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism","volume":"8","author":"Du","year":"2017","journal-title":"Nat Commun 24"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302560200","article-title":"The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia","volume":"278","author":"Leonard","year":"2003","journal-title":"J Biol Chem"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2347446","article-title":"Lipid nephrotoxicity mediated by HIF-1\u03b1 activation accelerates tubular injury in diabetic nephropathy","volume":"46","author":"Hu","year":"2024","journal-title":"Ren Fail"},{"key":"B116","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/ars.2022.0169","article-title":"Dapagliflozin alleviates diabetic kidney disease via hypoxia inducible factor 1\u03b1\/Heme oxygenase 1-mediated ferroptosis","volume":"40","author":"Wang","year":"2024","journal-title":"Antioxid Redox Signal"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.626390","article-title":"Ferroptosis enhanced diabetic renal tubular injury via HIF-1\u03b1\/HO-1 pathway in db\/db mice","volume":"12","author":"Feng","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2021.174","article-title":"The role of inflammation in diabetic kidney disease","volume":"36","author":"Jung","year":"2021","journal-title":"Korean J Intern Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.2174\/157339911794273928","article-title":"Obesity related kidney disease","volume":"7","author":"Mathew","year":"2011","journal-title":"Curr Diabetes Rev"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s00232-021-00206-w","article-title":"Sphingomyelin phosphodiesterase acid-like 3b is essential for toll-like receptor 3 signaling in human podocytes","volume":"255","author":"Watanabe","year":"2022","journal-title":"J Membr Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02203-y","article-title":"Immunohistochemical study for the expression of leukocyte adhesion molecules, and FGF23 and ACE2 in P","volume":"22","author":"Kajiwara","year":"2021","journal-title":"gingivalis LPS-induced Diabetic nephropathy. BMC Nephrol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41581-024-00889-z","article-title":"Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease","volume":"21","author":"Miguel","year":"2024","journal-title":"Nat Rev Nephrol. 7"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113965","article-title":"Therapeutic potential of pro-resolving mediators in diabetic kidney disease","volume":"178","author":"Vartak","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.49078","article-title":"FABP1 and FABP2 as markers of diabetic nephropathy","volume":"17","author":"Tsai","year":"2020","journal-title":"Int J Med Sci"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00186","article-title":"Free fatty acids and their metabolism affect function and survival of podocytes","volume":"5","author":"Sieber","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/1056-8727(95)80025-a","article-title":"The effect of macrophage colony-stimulating factor (M-CSF) on the progression of lipid-induced nephrotoxicity in diabetic nephropathy","volume":"9","author":"Utsunomiya","year":"1995","journal-title":"J Diabetes Complications"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1285797","article-title":"Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105502","article-title":"Fatty acids and inflammatory stimuli induce expression of long-chain acyl-CoA synthetase 1 to promote lipid remodeling in diabetic kidney disease","volume":"300","author":"Wang","year":"2024","journal-title":"J Biol Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1172\/jci85939","article-title":"Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury","volume":"126","author":"Pedigo","year":"2016","journal-title":"J Clin Invest"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13287","article-title":"Fetuin-a aggravates lipotoxicity in podocytes via interleukin-1 signaling","volume":"5","author":"Orellana","year":"2017","journal-title":"Physiol Rep"},{"key":"B132","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1042\/bst0320088","article-title":"Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors","volume":"32","author":"Ruan","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000217957.93135.c2","article-title":"Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines","volume":"26","author":"Ruan","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-015-0753-9","article-title":"Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy","volume":"52","author":"Zhang","year":"2015","journal-title":"Acta Diabetol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154748","article-title":"Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy","volume":"118","author":"Wu","year":"2021","journal-title":"Metabolism"},{"key":"B136","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-010-0605-4","article-title":"Interleukin-1\u03b2 enhances the intracellular accumulation of cholesterol by up-regulating the expression of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme a reductase in podocytes","volume":"346","author":"Zhang","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.177","article-title":"Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy","volume":"39","author":"Hu","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01304-5","article-title":"Simultaneous blockade of VEGF-b and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discovery"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1333429","article-title":"Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity","volume":"15","author":"Liang","year":"2024","journal-title":"Front Immunol"},{"key":"B140","article-title":"The role of complement in kidney disease","author":"Petr","year":"","journal-title":"Nat Rev Nephrol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/db19-0043","article-title":"Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility","volume":"69","author":"Tan","year":"2020","journal-title":"Diabetes"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx336","article-title":"Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy","volume":"33","author":"Yiu","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16157","article-title":"Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e96147","DOI":"10.1371\/journal.pone.0096147","article-title":"Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1\u03b1 in db\/db mice","volume":"9","author":"Hong","year":"2014","journal-title":"PloS One"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01106-6","article-title":"Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36\/fibrosis pathway","volume":"44","author":"Zou","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4617653","article-title":"Colquhounia root tablet promotes autophagy and inhibits apoptosis in diabetic nephropathy by suppressing CD36 expression in vivo and in vitro","volume":"2023","author":"Li","year":"2023","journal-title":"J Diabetes Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2018.7634","article-title":"Advanced oxidation protein products promote lipotoxicity and tubulointerstitial fibrosis via CD36\/\u03b2-catenin pathway in diabetic nephropathy","volume":"31","author":"Li","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy021","article-title":"The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy","volume":"33","author":"Hou","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.10.112","article-title":"CD36 is involved in high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells","volume":"468","author":"Hou","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115923","article-title":"Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36\/TRPC6\/NFAT2 signaling in type 2 diabetes mellitus mice","volume":"302","author":"Han","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155991","article-title":"Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2","volume":"134","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.165817","article-title":"Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy","volume":"8","author":"Lu","year":"2023","journal-title":"JCI Insight"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104778","article-title":"Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis","volume":"156","author":"Su","year":"2020","journal-title":"Pharmacol Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-022-00874-9","article-title":"Renal tubule ectopic lipid deposition in diabetic kidney disease rat model and in vitro mechanism of leptin intervention","volume":"78","author":"Liu","year":"2022","journal-title":"J Physiol Biochem"},{"key":"B155","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3892\/mmr.2021.11872","article-title":"FBXW7 mediates high glucose\u2212induced SREBP\u22121 expression in renal tubular cells of diabetic nephropathy under PI3K\/Akt pathway regulation","volume":"23","author":"Li","year":"2021","journal-title":"Mol Med Rep"},{"key":"B156","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jnutbio.2012.04.013","article-title":"Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats","volume":"24","author":"Soetikno","year":"2013","journal-title":"J Nutr Biochem"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.4922","article-title":"Renoprotective effect of curcumin against the combined oxidative stress of diabetes and nicotine in rats","volume":"13","author":"Ibrahim","year":"2016","journal-title":"Mol Med Rep"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2015.11.033","article-title":"Protective effect of thymol on high fat diet induced diabetic nephropathy in C57BL\/6J mice","volume":"245","author":"Saravanan","year":"2016","journal-title":"Chem Biol Interact"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1642","article-title":"Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy","volume":"56","author":"Jiang","year":"2007","journal-title":"Diabetes"},{"key":"B160","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/ijms19010137","article-title":"The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents renal and liver disease in western diet induced obesity mice","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28786","article-title":"1\u03b1,25(OH)(2) D(3) alleviates high glucose-induced lipid accumulation in rat renal tubular epithelial cells by inhibiting SREBPs","volume":"120","author":"Xu","year":"2019","journal-title":"J Cell Biochem"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.S2.S155","article-title":"Effect of bilirubin on triglyceride synthesis in streptozotocin-induced diabetic nephropathy","author":"Xu","year":"2014","journal-title":"J Korean Med Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1021\/jm101580m","article-title":"Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes","volume":"54","author":"Qian","year":"2011","journal-title":"J Med Chem"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice","volume":"292","author":"Wang","year":"2017","journal-title":"J Biol Chem"},{"key":"B165","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13098-022-00886-x","article-title":"New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation","volume":"14","author":"Sun","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.2174\/1381612828666220401143249","article-title":"Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33","volume":"28","author":"Ghaffari","year":"2022","journal-title":"Curr Pharm Des"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.730564","article-title":"Exendin-4 ameliorates lipotoxicity-induced glomerular endothelial cell injury by improving ABC transporter A1-mediated cholesterol efflux in diabetic apoE knockout mice","volume":"291","author":"Yin","year":"2016","journal-title":"J Biol Chem"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S90201","article-title":"Anthocyanins inhibit high-glucose-induced cholesterol accumulation and inflammation by activating LXR\u03b1 pathway in HK-2 cells","volume":"9","author":"Du","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.916620","article-title":"Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.06.029","article-title":"Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy","volume":"348","author":"He","year":"2022","journal-title":"J Control Release"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3095-6","article-title":"Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice","volume":"57","author":"Patel","year":"2014","journal-title":"Diabetologia"},{"key":"B172","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2022.12.088","article-title":"Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK\/NRF2 pathway","volume":"195","author":"Lu","year":"2023","journal-title":"Free Radic Biol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1549484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:27:02Z","timestamp":1745544422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1549484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":172,"alternative-id":["10.3389\/fimmu.2025.1549484"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1549484","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"article-number":"1549484"}}